Dynamic multispectral NIR/SWIR for in vivo lymphovascular architectural and functional quantification.
Christopher Hansen1, Jaidip Jagtap2, Abdul Parchur3
1Medical College of Wisconsin, Department of Biomedical Engineering, Milwaukee, Wisconsin, United States.
Journal of Biomedical Optics
|September 30, 2024
Summary
Shortwave-infrared (SWIR) imaging offers superior lymphatic vessel visualization compared to near-infrared first window (NIR-I) imaging. This advanced technique enhances lymphatic circulation assessment with improved resolution and sensitivity.
Area of Science:
- Biomedical Imaging
- Lymphatic System Research
- Optical Imaging Techniques
Background:
- The lymphatic system's crucial role in fluid balance and immunity is hindered by limited functional characterization methods.
- Current imaging techniques struggle with resolution and contrast for detailed lymphatic vessel analysis.
Purpose of the Study:
- To investigate the utility of shortwave-infrared (SWIR) fluorescence imaging for *in vivo* lymphatic structure and function assessment.
- To compare SWIR imaging with conventional near-infrared first window (NIR-I) imaging for lymphatic visualization.
Main Methods:
- Evaluated subsurface lymphatic circulation in Sprague-Dawley rats using NIR-I (700-900 nm) and SWIR (900-1800 nm) fluorescence imaging.
- Compared indocyanine green (ICG) and silver sulfide quantum dots (QDs) as contrast agents for SWIR lymphatic imaging after intradermal footpad injection.
Main Results:
- SWIR imaging demonstrated reduced scattering and autofluorescence compared to NIR-I.
- SWIR imaging with ICG showed 1.7x better resolution and sensitivity than NIR-I.
- SWIR imaging with QDs achieved nearly 2x better resolution and sensitivity, with enhanced vessel distinguishability.
Conclusions:
- SWIR imaging provides superior resolution and sensitivity for lymphatic vessel visualization compared to NIR-I.
- Silver sulfide QDs in SWIR imaging offer enhanced lymphatic imaging capabilities over ICG in NIR-I.
Related Concept Videos
Biosynthesis in Bacteria
1.0K
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
1.0K
Biosynthesis of Polysaccharides
984
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
984
Amino Acid Biosynthetic Pathways
1.8K
Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which...
1.8K
Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Production of Antibiotics
265
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
265


